These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38556142)
1. Synthesis of BLF1-containing trimethyl chitosan nanoparticles and evaluation of its immunogenicity and protection in syrian mice by oral and subcutaneous injections. Fazeli A; Honari H; Sadeghi D; Bakhtiari H Protein Expr Purif; 2024 Jul; 219():106462. PubMed ID: 38556142 [TBL] [Abstract][Full Text] [Related]
2. Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice. Chin CY; Tan SC; Nathan S Front Cell Infect Microbiol; 2012; 2():85. PubMed ID: 22919676 [TBL] [Abstract][Full Text] [Related]
3. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777 [TBL] [Abstract][Full Text] [Related]
4. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517 [TBL] [Abstract][Full Text] [Related]
5. Protective immunization against Enterohemorrhagic Escherichia coli and Shigella dysenteriae Type 1 by chitosan nanoparticle loaded with recombinant chimeric antigens comprising EIT and STX1B-IpaD. Mosadegh S; Abtahi H; Amani J; Karizi SZ; Salmanian AH Microb Pathog; 2023 Nov; 184():106344. PubMed ID: 37704060 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protective efficacy of Burkholderia pseudomallei BLF1-N and BLF1-C terminal domains against BLF1 toxin. Singh K; Singh AK; Uppalapati SR; Kingston JJ; Parida M Int Immunopharmacol; 2019 Dec; 77():105917. PubMed ID: 31675617 [TBL] [Abstract][Full Text] [Related]
11. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice. Su YC; Wan KL; Mohamed R; Nathan S Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831 [TBL] [Abstract][Full Text] [Related]
12. Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate. Scott AE; Ngugi SA; Laws TR; Corser D; Lonsdale CL; D'Elia RV; Titball RW; Williamson ED; Atkins TP; Prior JL J Immunol Res; 2014; 2014():392170. PubMed ID: 24892035 [TBL] [Abstract][Full Text] [Related]
13. Oral immunization of mice with Omp31-loaded Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667 [TBL] [Abstract][Full Text] [Related]
14. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application. Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523 [TBL] [Abstract][Full Text] [Related]
15. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization. Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469 [TBL] [Abstract][Full Text] [Related]
16. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688 [TBL] [Abstract][Full Text] [Related]
17. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis. Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423 [TBL] [Abstract][Full Text] [Related]
19. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model. Guo S; Yan W; McDonough SP; Lin N; Wu KJ; He H; Xiang H; Yang M; Moreira MA; Chang YF Vaccine; 2015 Mar; 33(13):1586-95. PubMed ID: 25698490 [TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection. Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]